The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease

Medicine and Dentistry

• Patient with Inflammatory Bowel Disease 100%
• Adverse Event 62%
• Leukopenia 50%
• Therapeutic Procedure 50%
• Nausea and Vomiting 25%
• Male 25%
• Female 25%
• Drug Therapy 12%
• Hepatitis 12%
• Bone Marrow Suppression 12%
• Mercaptopurine 12%
• Headache 12%
• Exanthem 12%
• Vomiting 12%
• Age 12%
• Azathioprine 12%
• Nausea 12%
• Disseminated Herpes Zoster 12%
• Arthralgia 12%

Nursing and Health Professions

• Adverse Event 62%
• Inpatient 50%
• Patient 50%
• Leukopenia 50%
• Nausea and Vomiting 25%
• Hepatitis 12%
• Medical Record 12%
• Headache 12%
• Azathioprine 12%
• Mercaptopurine 12%
• Herpes Zoster 12%
• Vomiting 12%
• Nausea 12%
• Maximum Tolerated Dose 12%
• Hospital 12%
• Rash 12%
• Arthralgia 12%
• Bone Marrow Suppression 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 62%
• Leukopenia 50%
• Nausea and Vomiting 25%
• Vomiting 12%
• Hepatitis 12%
• Azathioprine 12%
• Nausea 12%
• Bone Marrow Suppression 12%
• Headache 12%
• Arthralgia 12%
• Rash 12%
• Herpes Zoster 12%
• Mercaptopurine 12%